Article Text

Download PDFPDF

World Hip Trauma Evaluation (WHiTE): framework for embedded comprehensive cohort studies
  1. Matthew L Costa1,
  2. Xavier L Griffin1,
  3. Juul Achten1,
  4. David Metcalfe1,
  5. Andrew Judge2,
  6. Rafael Pinedo-Villanueva2,
  7. Nicholas Parsons3
  1. 1NDORMS (Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences), Kadoorie Centre, University of Oxford, John Radcliffe Hospital, Oxford, UK
  2. 2NDORMS (Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences), University of Oxford, Oxford, UK
  3. 3Warwick Medical School, University of Warwick, Coventry, UK
  1. Correspondence to Professor Matthew L Costa; Matthew.costa{at}ndorms.ox.ac.uk

Abstract

Introduction Osteoporotic hip fractures present a significant global challenge to patients, clinicians and healthcare systems. It is estimated that hip fracture accounts for 1.4% of total social and healthcare costs in the established market economies.

Methods and analysis The World Hip Trauma Evaluation (WHiTE) was set up to measure outcome in a comprehensive cohort of UK patients with hip fracture. All patients in the cohort are treated under a single comprehensive treatment pathway. A core outcome set, including health-related quality of life, is collected on all the patients. This protocol describes the current multicentre project that will be used as a vehicle to deliver a series of embedded observational studies.

Ethics and dissemination Research Ethics Committee approval was granted (Rec reference 11/LO/0927, approved 18/8/2011) and each hospital trust provided National Health Service (NHS) approvals.

Trial registration number The study is registered with National Institute of Health Research Portfolio (UKCRN ID 12351) and the ISRCTN registry (ISRCTN63982700).

  • ORTHOPAEDIC & TRAUMA SURGERY
  • TRAUMA MANAGEMENT

This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/

View Full Text

Statistics from Altmetric.com

Footnotes

  • Twitter Follow Xavier Griffin at @xlgriffin

  • Contributors MLC developed the study protocol and contributed to the writing of the manuscript. MLC is the chief investigator and main grant holder for this study. XLG developed the study protocol and contributed to the writing of the manuscript. JA developed the study protocol and contributed to the writing of the manuscript. DM developed the study protocol and contributed to the writing of the manuscript. AJ developed the study protocol and contributed to the writing of the manuscript. RP-V developed the study protocol and contributed to the writing of the manuscript. NP developed the study protocol and contributed to the writing of the manuscript.

  • Funding National Institute for Health Research. Grant number (10.13039/501100000272).

  • Competing interests None declared.

  • Ethics approval London-Camberwell St Giles Research Ethics Committee.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.